3-amino-7-(2-methylphenyl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-2-carbonitrile | 639481-44-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: 3-amino-7-(2-methylphenyl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-2-carbonitrile
• 英文别名: 3-Amino-7-(2-methylphenyl)-6-oxothieno[2,3-b]pyridine-2-carbonitrile
• CAS: 639481-44-0
• 化学式: C₁₅H₁₁N₃OS
• 分子量: 281.338
• InChiKey: YFGMSVRKWZFXQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  20
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  98.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  邻甲苯异硫氰酸酯 在 sodium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙醇 、 乙腈 为溶剂， 反应 8.0h， 生成 3-amino-7-(2-methylphenyl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-2-carbonitrile
  参考文献：
  名称：

  [EN] PROCESS FOR PREPARING 3-AMINOTHIENOPYRIDONE DERIVATIVES
  [FR] PROCEDE SERVANT A PREPARER DES DERIVES DE 3-AMINOTHIENOPYRIDONE

  摘要：

  本发明提供了一类在7位被芳基、杂芳基、环烷基或杂环烷基基团取代，在2位被特定范围的取代基团取代的3-氨基-7H-噻吩[2,3-b]吡啶-6-酮衍生物；还提供了制备这些化合物的方法，以及它们作为某些p38 MAP激酶抑制剂中间体的用途。

  公开号：

  WO2004113349A1

文献信息

• [EN] ARYLAMINE SUBSTUTUTED BICYCLIC HETEROAROMATIC COMPOUNDS AS P38 KINASE INHIBITORS<br/>[FR] COMPOSES BICYCLIQUES HETEROAROMATIQUES ARYLAMINE SUBSTITUEE UTILISES EN TANT QU'INHIBITEURS DE KINASE P38
  申请人：CELLTECH R&D LTD

  公开号：WO2004000846A1

  公开（公告）日：2003-12-31

  Bicyclic heteroaromatic derivatives of formula (1) are described: F (1) where: the dashed line joining A and C(Ra) is present and represents a bond and A is a -N= atom or a -C(Rb)= group, or the dashed line is absent and A is a -N(Rb)-, or -C(Rb)(Rc)- group; X is an -O-, -S- or substituted nitrogen atom or a -S(O)-, -S(O2)- or -NH­-group; Y is a nitrogen or substituted carbon atom or a -CH= group; n is zero or the integer 1; Alk1 is an optionally substituted aliphatic or heteroaliphatic chain L1 is a covalent bond or a linker atom or group; Cy1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group; Ar is an optionally substituted aromatic or heteroaromatic group; and the remaining substituents are defined in the specification. The compounds are potent and selective inhibitors of p38 kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders.

  公式（1）描述了具有双环杂芳衍生物：F（1）其中：连接A和C（Ra）的虚线存在且表示键，A是一个-N=原子或一个-C（Rb）=基团，或者虚线不存在且A是一个-N（Rb）-或-C（Rb）（Rc）-基团；X是一个-O-，-S-或取代的氮原子或一个-S（O）-，-S（O2）-或-NH­-基团；Y是一个氮或取代的碳原子或一个-CH=基团；n为零或整数1；Alk1是一个可选择取代的脂肪或杂原脂肪链L1是一个共价键或连接原子或基团；Cy1是一个氢原子或一个可选择取代的环脂肪，多环脂肪，杂环脂肪，多杂环脂肪，芳香或杂芳基团；Ar是一个可选择取代的芳香或杂芳基团；其余取代基在规范中定义。这些化合物是p38激酶的有效和选择性抑制剂，并可用于预防和治疗免疫或炎症性疾病。
• Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
  申请人：Brookings Christopher Daniel

  公开号：US20060004025A1

  公开（公告）日：2006-01-05

  Bicyclic heteroaromatic derivatives of formula (1) are described: F (1) where: the dashed line joining A and C(R a ) is present and represents a bond and A is a —N═ atom or a —C(R b )═ group, or the dashed line is absent and A is a —N(R b )—, or —C(R b )(R c )—group; X is an —O—, —S— or substituted nitrogen atom or a —S(O)—, —S(O 2 )— or —NH-group; Y is a nitrogen or substituted carbon atom or a —CH═ group; n is zero or the integer 1; Alk 1 is an optionally substituted aliphatic or heteroaliphatic chain L 1 is a covalent bond or a linker atom or group; Cy 1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group; Ar is an optionally substituted aromatic or heteroaromatic group; and the remaining substituents are defined in the specification. The compounds are potent and selective inhibitors of p38 kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders.

  描述了式（1）的双环杂芳基衍生物：F（1），其中：连接A和C（Ra）的虚线存在且表示化学键，A是- N═原子或- C（Rb）═基团，或虚线不存在，A是- N（Rb）-，或- C（Rb）（Rc）-基团；X是- O-，- S-或取代的氮原子或- S（O）-，- S（O2）-或- NH-基团；Y是氮或取代的碳原子或- CH═基团；n为零或整数1；Alk1是可选的取代的脂肪或杂脂肪链；L1是共价键或连接原子或基团；Cy1是氢原子或可选的取代的环脂肪，多环脂肪，杂环脂肪，多杂环脂肪，芳香或杂芳香基团；Ar是可选的取代的芳香或杂芳香基团；其余取代基在说明书中定义。这些化合物是p38激酶的有效和选择性抑制剂，并可用于预防和治疗免疫或炎症性疾病。
• Bicyclic Heteroaromatic Derivatives
  申请人：Brookings Daniel Christopher

  公开号：US20090042877A1

  公开（公告）日：2009-02-12

  Bicyclic heteroaromatic derivatives of formula (1) are described: F (1) where: the dashed line joining A and C(R a ) is present and represents a bond and A is a —N═ atom or a —C(R b )═ group, or the dashed line is absent and A is a —N(R b )—, or —C(R b )(R c )— group; X is an —O—, —S— or substituted nitrogen atom or a —S(O)—, —S(O 2 )— or —NH-group; Y is a nitrogen or substituted carbon atom or a —CH═ group; n is zero or the integer 1; Alk 1 is an optionally substituted aliphatic or heteroaliphatic chain L 1 is a covalent bond or a linker atom or group; Cy 1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group; Ar is an optionally substituted aromatic or heteroaromatic group; and the remaining substituents are defined in the specification. The compounds are potent and selective inhibitors of p38 kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders.

  描述了公式（1）的双环杂芳基衍生物：F（1）其中：连接A和C（Ra）的虚线存在并表示键，并且A是- N═原子或- C（Rb）═基团，或者虚线不存在并且A是- N（Rb）-或- C（Rb）（Rc）-基团; X是- O-，- S-或取代的氮原子或- S（O）-，- S（O2）-或- NH-基团; Y是氮或取代的碳原子或- CH═基团; n为零或整数1; Alk1是可选取代的脂肪或杂脂肪链L1是共价键或连接原子或基团; Cy1是氢原子或可选取代的环脂肪，多环脂肪，杂环脂肪，多杂环脂肪，芳香或杂芳香基团; Ar是可选取代的芳香或杂芳香基团; 其余取代基在说明书中定义。这些化合物是p38激酶的有效选择性抑制剂，并可用于预防和治疗免疫或炎症性疾病。
• Process for preparing 3-aminothienopyridone derivatives
  申请人：Evans Robert Graham

  公开号：US20070191608A1

  公开（公告）日：2007-08-16

  This invention provides a class of 3-amino-7H-thieno[2,3-b]pyridin-6-one derivatives, substituted in the 7-position by an aryl, heteroaryl, cycloalkyl or heterocycloalkyl moiety, and in the 2-position by a specified range of substituent groups; also provided is a process for preparing those compounds, and the use thereof as intermediates in the manufacture of certain p38 MAP kinase inhibitors.

  本发明提供了一类3-氨基-7H-噻吩[2,3-b]吡啶-6-酮衍生物，其在7-位被芳基，杂环芳基，环烷基或杂环烷基取代，而在2-位被指定范围的取代基取代；还提供了一种制备这些化合物的方法，并将其用作制造某些p38 MAP激酶抑制剂的中间体。
• AQUEOUS COATING-FILM-FORMING COMPOSITION FOR FORMING LUBRICATING COATING FILM, AND AIR BAG USING SAID COMPOSITION
  申请人：Dow Toray Co., Ltd.

  公开号：EP3988620A1

  公开（公告）日：2022-04-27

  [Problem] To provide an aqueous coating film-forming composition of the present invention that can be coated uniformly on a silicone rubber surface without causing repelling or coating failure even when applied in the silicone rubber surface at a film thickness of 30 µm or less, and forms an antifriction dry coating film that reduces friction and/or blocking of the substrate surface on the surface. [Resolution Means] An aqueous coating film-forming composition for forming an antifriction dry coating film that reduces friction and/or blocking of a surface of a substrate, containing (A) a solid lubricant, (B) a thickener, and (C) a silicone binder in the form of an oil-in-water silicone emulsion containing (c1) an ionic emulsifier and (c2) a polyoxyethylene-polyoxypropylene copolymerized nonionic emulsifier, where water content is removed to form an antifriction dry coating film containing 40 to 80 mass% the aforementioned component (A), 0.50 to 10 mass% of the aforementioned component (B), 0.60 to 5 mass% of the aforementioned component (c2), and 5 to 49.5 mass% of aforementioned component (C) (solid fraction); as well as an application thereof (particularly including airbag coating)

  问题 提供一种本发明的水性涂料成膜组合物，该组合物可以均匀地涂布在硅橡胶表面，即使涂布在硅橡胶表面的膜厚为 30 µm 或更薄，也不会导致排斥或涂布失败，并且形成的防摩擦干涂膜可以减少基材表面对表面的摩擦和/或阻塞。 [解析手段］ 一种用于形成可减少基材表面摩擦和/或阻塞的抗摩擦干涂膜的水性涂膜成膜组合物，含有 (A) 固体润滑剂，(B) 增稠剂、和 (C) 有机硅粘合剂，其形式为水包油型有机硅乳液，含有 (c1) 离子乳化剂和 (c2) 聚氧乙烯-聚氧丙烯共聚非离子乳化剂，其中水含量被去除以形成抗摩擦干涂膜，其中含有 40 至 80 质量％的上述组分 (A)、0.50%至 10%的上述组分 (B)、0.60%至 5%的上述组分 (c2)和 5%至 49.5%的上述组分 (C)（固体组分）；以及其应用（尤其包括安全气囊涂层）